- Description
-
Details
(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoic acid - Additional Information
-
Additional Information
Catalog Number 48046 CAS 24277-39-2 M.W. 303.35 Formula C14H25NO6 IUPAC Name (4S)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoic acid Synonym No Also Known As - (4S)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoic acid
- (4S)-5-tert-butoxy-4-(tert-butoxycarbonylamino)-5-oxo-pentanoic acid
- (4S)-5-tert-butoxy-4-[(tert-butoxy-oxomethyl)amino]-5-oxopentanoic acid
- (4S)-5-tert-butoxy-4-(tert-butoxycarbonylamino)-5-keto-valeric acid
- (4S)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxo-pentanoic acid
- 15109_FLUKA
- Boc-Glu-OtBu
- Boc-L-glutamic acid 1-tert-butyl ester
- B2522_SIGMA
InChIKey YMOYURYWGUWMFM-VIFPVBQESA-N InChI InChI=1S/C14H25NO6/c1-13(2,3)20-11(18)9(7-8-10(16)17)15-12(19)21-14(4,5)6/h9H,7-8H2,1-6H3,(H,15,19)(H,16,17)/t9-/m0/s1 SMILES CC(C)(C)OC(=O)[C@H](CCC(=O)O)NC(=O)OC(C)(C)C - Cited Uses
-
Details
1. Wang L et al, "Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents", Nuclear medicine and biology, 39(7) pp.933-943 (2012 Oct).2. Treweek JB et al, "Prevention of Drug-induced Memory Impairment by Immunopharmacotherapy", Journal of medicinal chemistry, 51(21) pp.6866-6875 (2008 Nov 13).3. Frison N et al, "Oligolysine-based saccharide clusters: synthesis and specificity.", Biochemical Journal, 368(Pt 1) pp.111-119 (2002 Nov 15). - Reviews
-
Peptides & Peptide Synthesis Products